Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Neovasc logo

About Neovasc Stock (NASDAQ:NVCN)

Advanced Chart

Key Stats

Today's Range
$30.03
$30.03
50-Day Range
$29.03
$30.03
52-Week Range
$4.59
$30.07
Volume
1 shs
Average Volume
56,993 shs
Market Capitalization
$82.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

Closing Bell: Neovasc Inc down on Tuesday (NVCN)
Closing Bell: Neovasc Inc up on Monday (NVCN)
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Neovasc Announces German Reimbursement Renewal
See More Headlines

NVCN Stock Analysis - Frequently Asked Questions

Neovasc Inc. (NASDAQ:NVCN) issued its quarterly earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) EPS for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider had revenue of $0.70 million for the quarter, compared to the consensus estimate of $1.20 million. Neovasc had a negative net margin of 1,082.92% and a negative trailing twelve-month return on equity of 127.25%.

Neovasc shares reverse split before market open on Friday, April 29th 2022.The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Micron Technology (MU) and Canopy Growth (CGC).

Company Calendar

Last Earnings
11/09/2021
Today
7/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVCN
Employees
49
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$41.20 million
Net Margins
-1,082.92%
Pretax Margin
-1,082.26%

Debt

Sales & Book Value

Annual Sales
$3.81 million
Price / Cash Flow
N/A
Book Value
$5.77 per share
Price / Book
5.20

Miscellaneous

Free Float
N/A
Market Cap
$82.28 million
Optionable
Not Optionable
Beta
1.70

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:NVCN) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners